Georgios Alexiou
About Georgios Alexiou
Georgios Alexiou is a Cell Therapy Specialist at Kite Pharma, where he has worked since 2019. He trains new team members in CAR-T cell therapy production, authors documentation, and conducts root cause analysis in the manufacturing department.
Work at Kite Pharma
Georgios Alexiou has been employed at Kite Pharma as a Cell Therapy Specialist since 2019. In this role, he trains new manufacturing team members on CAR-T cell therapy production processes. He also authors and reviews documentation to support new versions of CAR-T cell therapy manufacturing documentation. His responsibilities include performing root cause analysis and implementing Corrective and Preventive Actions (CAPA) for deviations within the manufacturing department. Additionally, he acts as a process project owner, focusing on continuous improvement and promoting Lean Six Sigma methodologies in CAR-T cell manufacturing.
Education and Expertise
Georgios Alexiou studied at the University of Thessaly, where he completed a one-year program in Human/Medical Genetics from 2013 to 2014. He also earned a degree in Biochemistry and Biotechnology from the same institution, studying from 2008 to 2013. His educational background provides him with a solid foundation in the scientific principles underlying cell therapy and biomanufacturing processes.
Background
Before joining Kite Pharma, Georgios Alexiou worked as a Medical Technologist at PPD from 2018 to 2019 in the Brussels Area, Belgium. This experience contributed to his expertise in laboratory processes and quality control, which are critical in the field of cell therapy manufacturing.
Achievements in Manufacturing Processes
In his current role at Kite Pharma, Georgios Alexiou is actively involved in improving CAR-T cell therapy manufacturing processes. He supports continuous improvement initiatives and promotes Lean Six Sigma performance, which enhances operational efficiency and product quality in the manufacturing environment.